Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication.

CONCLUSIONS: Our findings are inconclusive as to the possible effect of metformin on the prognosis of endometrioid EC in women with T2D. However, use of metformin may reduce mortality from other causes.
PMID: 29054569 [PubMed - as supplied by publisher]

Source: Gynecologic Oncology - October 17, 2017 Category: Cancer & Oncology Authors: Arima R, Hautakoski A, Marttila M, Arffman M, Sund R, Ilanne-Parikka P, Kangaskokko J, Hinkula M, Puistola U, Läärä E Tags: Gynecol Oncol Source Type: research